Protagenic Therapeutics Inc. (PTIX)

[Barney Vissur]

who cares..."panic selling???"...this company's success or failure will be based on earnings and the people involved. Spyder may be the major revenue-driving product going forward, so it should be very interesting to see what it's about in detail, but I don't think Spyder showing up on the website is going to rain cash on anyone...not immediately, anyway.

If the billionaires Dyne and Chazen are satisfied with being failures, this company will fail, but if they loathe failing and follow their proven records of success, ATRN will succeed. If Goldfarb's statements in the conference call stating the increase in revenues would be "significant" is proved to be untrue, then his credibility will be tested going forward.